300357 我武生物
按盤價 
23.400 +0.410 (+1.783%)
23.400 +0.410 (+1.783%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.979 | 14.896 | 18.773 | 21.178 | 20.420 |
| 總資產報酬率 ROA (%) | 10.346 | 13.033 | 16.890 | 19.113 | 18.361 |
| 投入資產回報率 ROIC (%) | 11.547 | 14.421 | 18.506 | 21.113 | 19.116 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.257 | 95.262 | 95.393 | 95.736 | 95.514 |
| 營業利潤率 (%) | 43.298 | 40.672 | 44.219 | 48.645 | 50.537 |
| 息稅前利潤/營業總收入 (%) | 39.766 | 37.312 | 41.799 | 45.914 | 47.063 |
| 淨利潤/營業總收入 (%) | 35.947 | 34.841 | 37.469 | 40.398 | 42.396 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.537 | 96.618 | 102.515 | 94.079 | 93.968 |
| 價值變動淨收益/利潤總額(%) | 1.824 | 0.360 | 0.676 | 1.600 | 1.236 |
| 營業外收支淨額/利潤總額(%) | -0.847 | 0.284 | 0.637 | 0.023 | 0.340 | 償債能力分析 |
| 流動比率 (X) | 10.091 | 8.867 | 14.376 | 12.422 | 21.129 |
| 速動比率 (X) | 9.770 | 8.534 | 13.905 | 11.924 | 20.256 |
| 資產負債率 (%) | 8.578 | 10.088 | 7.769 | 7.006 | 4.774 |
| 帶息債務/全部投入資本 (%) | 0.401 | 0.467 | -1.137 | -1.068 | -- |
| 股東權益/帶息債務 (%) | 24,164.472 | 20,537.318 | -8,595.943 | -9,315.131 | -7,211.267 |
| 股東權益/負債合計 (%) | 1,018.746 | 845.429 | 1,159.304 | 1,282.590 | 1,900.473 |
| 利息保障倍數 (X) | -12.552 | -10.734 | -15.460 | -16.742 | -12.908 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 68.921 | 66.650 | 65.734 | 64.711 | 0.000 |
| 存貨周轉天數 (天) | 434.806 | 481.237 | 445.498 | 533.562 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
